BD wins Frost and Sullivan company of the year award

BD has been named as global company of the year for the clinical and research flow cytometry sector by Frost and Sullivan.

The firm was selected for the accolade after Frost and Sullivan analysts independently evaluated candidates based on three key factors: visionary innovation, performance and customer impact.

BD was recognised for its large and diverse customer base, broad product portfolio, consistent track record of reliability and supply chain excellence, as well as its high standard of customer service.

It was acclaimed for being first to market with a number of innovative products, as well as establishing clear credibility for its offerings among end users.

Claude Dartiguelongue, worldwide president of biosciences for BD, said: "BD has partnered with our global research and clinical customers to expand knowledge of the single cell. Today, these discoveries and applications help to improve the diagnosis and understanding of many different diseases impacting the world."

The company employs 45,000 employees across 50 countries.